Nuclear Imaging Market (2011 - 2016) - Competitive Landscape & Global Forecasts to 2016
Nuclear imaging is most popularly used for cardiovascular and oncology applications. Gamma camera imaging is used in myocardial and cerebral perfusion studies. Positron emission tomography (PET) imaging enables clinicians to identify chemical and physiologic changes in targeted tissues earlier. Hybrid positron emission tomography/computed tomography (PET/CT) enables the fusion of images and is most popularly used in radiosurgery planning. This technology allows clinicians to plan the best orientation of radiation beams for the treatment of disease with good accuracy. The global nuclear medicine market was around $1.45 billion in the year 2010 and is expected to reach $2.01 billion in 2016 with an expected CAGR of around 5.87% from the year 2011 to 2016. Nuclear imaging market is exhibiting sound growth particularly in the cardiac segment amid the rising attention that cardiac disease prevention and treatment is getting. The players have offered latest technology in order to remain in the competitive market.
Benchmarking the rapid strategy shifts of the Top 100 companies in the Nuclear Imaging MarketRequest For Special Pricing